These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7503715)
1. Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL. Nakajima T; Sakagishi Y; Katahira T; Nagata A; Kuwae T; Nakamura H; Inoue I; Takahashi K; Katayama S; Komoda T Biochem Biophys Res Commun; 1995 Dec; 217(2):407-11. PubMed ID: 7503715 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma. Nakajima T; Matsunaga T; Kawai S; Hokari S; Inoue I; Katayama S; Nagata A; Komoda T Ann Clin Biochem; 2004 Jul; 41(Pt 4):309-15. PubMed ID: 15298743 [TBL] [Abstract][Full Text] [Related]
3. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins. Radulescu L; Stancu C; Antohe F Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494 [TBL] [Abstract][Full Text] [Related]
4. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions. Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427 [TBL] [Abstract][Full Text] [Related]
6. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody-based immunoassay for evaluation of lipoprotein oxidation. Preobrazhensky S; Trakht I; Chestkov V; Wentz M Anal Biochem; 1995 May; 227(1):225-34. PubMed ID: 7545355 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein inhibits in vitro oxidation of low-density lipoprotein. Rufail ML; Ramage SC; van Antwerpen R FEBS Lett; 2006 Oct; 580(22):5155-60. PubMed ID: 16962105 [TBL] [Abstract][Full Text] [Related]
10. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes. Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde. Choi JW; Kim DJ; Rhim JH; Chung JH; Chung HK Hybrid Hybridomics; 2003 Aug; 22(4):259-62. PubMed ID: 14511571 [TBL] [Abstract][Full Text] [Related]
13. [Role of lipoprotein bound copper ions in lipid peroxidation of low and high density lipoproteins]. Vakhrusheva TV; Dremina ES; Sharov VS; Azizova OA Biofizika; 1997; 42(3):662-70. PubMed ID: 9296625 [TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of phosphatidylcholine hydroperoxides during copper oxidation of LDL and HDL by liquid chromatography/mass spectrometry. Hui SP; Taguchi Y; Takeda S; Ohkawa F; Sakurai T; Yamaki S; Jin S; Fuda H; Kurosawa T; Chiba H Anal Bioanal Chem; 2012 Jun; 403(7):1831-40. PubMed ID: 22367245 [TBL] [Abstract][Full Text] [Related]
15. CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis. Thorne RF; Mhaidat NM; Ralston KJ; Burns GF FEBS Lett; 2007 Mar; 581(6):1227-32. PubMed ID: 17346709 [TBL] [Abstract][Full Text] [Related]
16. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients. Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163 [TBL] [Abstract][Full Text] [Related]
17. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia. Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122 [TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins. Loued S; Isabelle M; Berrougui H; Khalil A Life Sci; 2012 Jan; 90(1-2):82-8. PubMed ID: 22067439 [TBL] [Abstract][Full Text] [Related]
19. Oxidized lipoproteins induce long-lasting inhibition of nitric oxide synthase from a murine endothelioma cell line (bEnd.4). Fogliatto G; Musanti R; Pirillo A; Ghiselli G J Cardiovasc Risk; 1995 Apr; 2(2):123-30. PubMed ID: 7541706 [TBL] [Abstract][Full Text] [Related]
20. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia. Bai H; Liu BW; Deng ZY; Shen T; Fang DZ; Zhao YH; Liu Y Free Radic Biol Med; 2006 May; 40(10):1796-803. PubMed ID: 16678017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]